decision analysis software program data, version 3.5 (treeage software)
90
Structured Review
treeage software
decision analysis software program data, version 3.5
Decision Analysis Software Program Data, Version 3.5, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/decision+analysis+software+program+data+3%2E5/data+software+version+3+5/pm11101066-36-6-13
Average 90 stars, based on 1 article reviews
Decision Analysis Software Program Data, Version 3.5, supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/decision+analysis+software+program+data+3%2E5/data+software+version+3+5/pm11101066-36-6-13
Average 90 stars, based on 1 article reviews
decision analysis software program data, version 3.5 - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Cost-effectiveness of pegfilgrastim versus 6-day filgrastim primary prophylaxis in patients with non-Hodgkin's lymphoma receiving CHOP-21 in United States. Article Snippet: Objectives: Prophylaxis with granulocyte-colony stimulating factor (G-CSF) reduces the risk of febrile neutropenia (FN) in patients receiving myelosuppressive chemotherapy.. Randomized clinical trials have shown that pegfilgrastim, a 2nd-generation G-CSF, is at least as effective as the 1st-generation G-CSF filgrastim.. In the meta-analysis of trials pegfilgrastim performed better than filgrastim with respect to FN risk. Article Title: The Clinical Impact of 2 Different Strategies for Initiating Therapy in Patients With Ocular Hypertension Article Snippet: Methods: Using a simulation model, initiating therapy with timolol (strategy 1) and with latanoprost (strategy 2) was simulated for a hypothetic cohort of ocular hypertension patients with an initial IOP distribution (data of 1000 patients).. Adjustment of therapy within 15 months and a subsequent lifelong follow-up, with an IOP dependent conversion to glaucoma, were modeled.. The IOP lowering effect of medication (based on a meta-analysis) was applied by Monte Carlo simulation. Article Title: Current and projected gaps in the availability of radiotherapy in the Asia-Pacific region: a country income-group analysis Article Snippet: The CCORE models were constructed and hosted on Article Title: Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda Article Snippet: A Construct:Article Title: Cost–utility analysis of an adjunctive recombinant activated factor VIIa for on-demand treatment of bleeding episodes in dengue haemorrhagic fever Article Snippet: The present study aimed to assess the cost–utility analysis of using an adjunctive recombinant activated factor VIIa (rFVIIa) in children for controlling life-threatening bleeding in dengue haemorrhagic fever (DHF)/dengue shock syndrome (DSS).. We constructed a decision-tree model, comparing a standard care and the use of an additional adjuvant rFVIIa for controlling life-threatening bleeding in children with DHF/DSS.. Cost and utility benefit were estimated from the societal perspective. Article Title: Cost Analysis and Provider Satisfaction With Pediatrician in Triage Article Snippet: Objectives: The goals of this study were to (1) conduct a cost-benefit analysis, from a hospital’s perspective, of using a pediatrician in triage (PIT) in the emergency department (ED) and (2) assess the impact of a physician in triage on provider satisfaction.. Methods: This was a prospective, controlled trial of PIT (intervention) versus conventional registered nurseYdriven triage (control), at an urban, academic, tertiary level pediatric ED, which led to a cost-benefit analysis by looking at the effect that PIT has on length of stay (LOS) and thus on ED revenue.. Provider satisfaction was assessed through surveys. Software:Article Title: Cost–utility analysis of an adjunctive recombinant activated factor VIIa for on-demand treatment of bleeding episodes in dengue haemorrhagic fever Article Snippet: The present study aimed to assess the cost–utility analysis of using an adjunctive recombinant activated factor VIIa (rFVIIa) in children for controlling life-threatening bleeding in dengue haemorrhagic fever (DHF)/dengue shock syndrome (DSS).. We constructed a decision-tree model, comparing a standard care and the use of an additional adjuvant rFVIIa for controlling life-threatening bleeding in children with DHF/DSS.. Cost and utility benefit were estimated from the societal perspective. Article Title: The cost-utility analysis of 18-fluoro-2-deoxyglucose positron emission tomography in the diagnosis of recurrent nasopharyngeal carcinoma. Article Snippet: Results.. After inputting the data for utilities and life expectancies into the decision tree model, the quality-adjusted life expectancies turn out to be 16.16 quality-adjusted life-years (QALYs) for strategy 1, 16.70 QALYs for strategy 2, and 17.35 QALYs for strategy 3.. The additional cost per additional QALYs for strategy 3 relative to strategy 1 is calculated to be US $462. Article Title: Effectiveness of timing strategies for delivery of monochorionic diamniotic twins. Article Snippet: Monochorionic diamniotic twins account for 20% of twin gestations.. Women with these pregnancies ave an increased risk of adverse perinaal outcomes that include preterm delivry, fetal growth restriction, fetal anomlies, twin-twin transfusion syndrome, nd stillbirth.. Of particular concern, even ith antenatal surveillance that indicates oncordant twin growth, reassuring fetal esting, and an absence of features that are uggestive of twin-twin transfusion synrome, an increased risk of fetal death reains that may be as high as 4.6% after 32 Article Title: Cost Analysis and Provider Satisfaction With Pediatrician in Triage Article Snippet: Objectives: The goals of this study were to (1) conduct a cost-benefit analysis, from a hospital’s perspective, of using a pediatrician in triage (PIT) in the emergency department (ED) and (2) assess the impact of a physician in triage on provider satisfaction.. Methods: This was a prospective, controlled trial of PIT (intervention) versus conventional registered nurseYdriven triage (control), at an urban, academic, tertiary level pediatric ED, which led to a cost-benefit analysis by looking at the effect that PIT has on length of stay (LOS) and thus on ED revenue.. Provider satisfaction was assessed through surveys. Derivative Assay:Article Title: Cost Analysis and Provider Satisfaction With Pediatrician in Triage Article Snippet: Objectives: The goals of this study were to (1) conduct a cost-benefit analysis, from a hospital’s perspective, of using a pediatrician in triage (PIT) in the emergency department (ED) and (2) assess the impact of a physician in triage on provider satisfaction.. Methods: This was a prospective, controlled trial of PIT (intervention) versus conventional registered nurseYdriven triage (control), at an urban, academic, tertiary level pediatric ED, which led to a cost-benefit analysis by looking at the effect that PIT has on length of stay (LOS) and thus on ED revenue.. Provider satisfaction was assessed through surveys. |